Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Denmark Germany Italy Poland Slovakia +1
  • Study on the Effects of Inhaled Budesonide, Glycopyrronium Bromide, and Formoterol Fumarate Dihydrate in Patients with Stable COPD

    Recruiting

    3 1 1 1
    Investigated Diseases:
    France
  • Study of alpha-1 antitrypsin given intravenously to hospitalized patients during COPD exacerbation

    Recruiting

    2 1 1
    Investigated Diseases:
    Italy
  • Study of Piperacillin/Tazobactam and Levofloxacin for Patients with COPD or Cystic Fibrosis

    Recruiting

    3 1 1 1
    Austria
  • Study of Azithromycin Treatment Based on Mucus Changes in Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on the Effects of Tezepelumab on Airway Inflammation in Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Bulgaria Czechia Denmark Finland France +10
  • Study on Budesonide for COPD Patients with Different Eosinophil Levels

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany The Netherlands Spain
  • Study on Oxygen Therapy and Drug Combination for Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Denmark
  • A study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.

    Recruiting

    3 1 1
    Investigated Diseases:
    Belgium Bulgaria Denmark France Germany Greece +6